Accession Number:

ADA523389

Title:

Fenoldopam Use in a Burn Intensive Care Unit: A Retrospective Study

Descriptive Note:

Journal article

Corporate Author:

ARMY INST OF SURGICAL RESEARCH FORT SAM HOUSTON TX

Report Date:

2010-01-01

Pagination or Media Count:

27.0

Abstract:

Fenoldopam mesylate is a highly selective dopamine-1 receptor agonist approved for the treatment of hypertensive emergencies that may have a role at low doses in preserving renal function in those at high risk for or with acute kidney injury AKI. There is no data on low-dose fenoldopam in the burn population. The purpose of our study was to describe our use of lowdose fenoldopam 0.030.09 microgramskgmin infusion in critically ill burn patients with AKI.a

Subject Categories:

  • Anatomy and Physiology
  • Medicine and Medical Research

Distribution Statement:

APPROVED FOR PUBLIC RELEASE